The prevalence of ovarian cancer in BRCA1 mutation carriers is 1.5% in <40 years of age and increases up to 10–21% by 50 years of age, while in BRCA2 mutation carriers, the risk is less than 3–5% by 50 years of age [19,20]. The gene discussed is BRCA2; the disease is ovarian cancer.